Cologne

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Hepatitis B1 trial
• HIV1 trial
• Lupus (SLE)1 trial
• Polycystic kidney disease1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 12 trials
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• GlaxoSmithKline4 trials
• ViiV Healthcare1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

  NCT06734234· Phase 1· GlaxoSmithKline· Source

• Active, not recruiting

  Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

  NCT04915755· Phase 3· GlaxoSmithKline· Source

Closed trials

• Completed

  A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

  NCT05561673· Phase 1· GlaxoSmithKline· Source

• Completed

  Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

  NCT03754803· ViiV Healthcare· Source

• Completed

  Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

  NCT01729455· GlaxoSmithKline· Source